In 2331 patients with CHF and LVEF < 35% in the US HF-ACTION study [59], sST2 was significantly associated with CV mortality and HF hospitalization, as well as with all-cause mortality, even after accounting for confounders including NT-proBNP. Here, NPPB is linked to congestive heart failure.